Agreement - February 21, 2014
Nuevolution enters license agreement with Merck
Nuevolution A/S has announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc. The agreement involves small molecule compounds targeting an undisclosed intracellular target for use as leads in Merck’s drug discovery and development. Under terms of the agreement, Merck will gain exclusive rights for the further development and […]
Agreement - February 13, 2014
Enzymatica starts sale of ColdZyme at airports
The company has signed an agreement with pharmaceutical wholesaler Pharmaxim to distribute ColdZyme at Swedish airports. Air-passengers are an important target group for Enzymatica’s cold treatment spray, claims the company, refering to a US study which has shown that one in five passengers catch a cold after a flight. The company further states that ColdZyme Mouth […]
Agreement - February 10, 2014
Sectra signs large healthcare agreement
The IT and medtech company has announced an order to the value of SEK 32 million for a four-year agreement. The agreement includes development, maintenance and support for a Scandinavian customer’s regional IT solution for managing medical images and patient information, the Sectra RIS and PACS. “We work purposefully to increase customer satisfaction by providing […]
Agreement - January 29, 2014
FOB Synthesis enters into license agreement with AstraZeneca
FOB Synthesis has entered into a research and development option and license agreement with AstraZeneca for the development of a novel antibiotic to treat drug-resistant bacterial infections. The treatment will potentially combine compounds from AstraZeneca’s preclinical beta lactamase inhibitor (BLI) and FOB Synthesis’ preclinical Carbapenem antibiotic programs to help break down bacteria’s resistance to carbapenems. […]
Agreement - January 27, 2014
Sectra enters the US medical education market
Sectra has signed a partnership agreement with Touch of Life Technologies. Under the agreement, ToLTech will become a distributor of Sectra’s medical education solutions including the visualization table in the US and Canada. A new version of the Sectra Table will be presented publicly at the IMSH Congress in San Francisco, US on January 25-29. As […]
Agreement - January 15, 2014
Orion Corporation signs license agreement with Janssen Pharmaceuticals
Orion Corporation has entered into a license agreement with Janssen Pharmaceuticals for the development and commercialization of Orion’s novel, investigational alpha-2c adrenoceptor antagonists for the symptoms of Alzheimer’s disease, including a clinical phase compound ORM-12741. According to the agreement, Orion will receive an upfront payment of USD 31 million and is eligible to receive milestone […]
